The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)

NCT03159884 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Polypoidal Choroidal Vasculopathy (PCV)

Interventions

DRUG: Conbercept

Sponsor

Chengdu Kanghong Biotech Co., Ltd.